by Harvard University This illustration shows how a ciVax infection vaccine against a pathogenic E. coli strain is produced and applied. First, carbohydrate-containing surface molecules (PAMPs) of killed bacteria are captured with magnetic beads coated with FcMBL. The beads are then combined with mesoporous silica (MPS) rods, immune cell-recruiting GMCSF, and immune cell-activating CpG adjuvant to...
